Table 5.
Association between AKI severity and renal recovery by CMS DOT (N = 138 patients).
| Total CMS-Induced AKI (N = 138 Cases) (%) | AKI Occurring 2 Days after CMS Therapy Initiation (%) | AKI Occurring between 3 Days and <7 Days after CMS Therapy Initiation (%) | AKI Occurring at ≥7 Days of CMS Therapy Initiation (%) | p-Value | |
|---|---|---|---|---|---|
| Total AKI | 138 | 46 (33.3%) | 32 (23.2%) | 60 (43.5%) | |
| Severity of CMS-induced AKI | |||||
| Stage 1 | 52/138 (37.7%) | 28/46 (60.9%) | 13/32 (40.6%) | 11/60 (18.3%) | <0.0001 |
| Stage 2 or 3 | 86/138 (62.3%) | 18/46 (39.1%) | 19/32 (59.4%) | 49/60 (81.7%) |
Abbreviations: AKI = acute kidney injury, CMS = colistimethate sodium.